OCTOBER 2024 NEWSLETTER

  • Laura Ejarque
  • October 24, 2024
  • 8 min read

We’re excited and proud to launch our new quarterly newsletter!
To make sure you receive it, please sign up.

Read More

The FDA’s Center for Drug Evaluation and Research (CDER) has accepted the first letter of intent (LOI) into its ISTAND Pilot Program for organs-on-chip technology. This LOI is for a human Liver-Chip used to assess the risk of DILI in adults to create relevant data for a drug’s investigational new drug (IND) submission. This LOI acceptance marks a major step forward for CIVM in general.

Read More

Recent Comments

No comments to show.

Recent Comments

    Subscribe To Our Quarterly Newsletter

    Keep up to date with the latest advances in organs-on-chip